Skip to main content
. 2007 May 21;66(11):1497–1502. doi: 10.1136/ard.2006.067603

Table 2 HLA‐DRB1 serotype frequencies observed in patients with RA and control subjects .

Serotype BRASS Control
n (%) SE, n (%) D70, n (%) n (%) SE, n (%) D70, n (%)
DR1 180 (13.1) 168 (93.3) 12 (6.7) 114 (11.8) 102 (89.5) 12 (10.5)
DR2 (15) 148 (10.7) 119 (12.3)
DR2 (16) 22 (1.6) 22 (100) 12 (1.2) 12 (100)
DR3 147 (10.7) 121 (12.6)
DR4 479 (34.8) 428 (89.4) 24 (5) 168 (17.4) 138 (82.1) 10 (6)
DR7 100 (7.3) 100 (100) 127 (13.2) 127 (100)
DR8 25 (1.8) 25 (100) 22 (2.3) 22 (100)
DR9 12 (0.9) 5 (0.5)
DR10 23 (1.7) 23 (100) 7 (0.7) 7 (100)
DR11/DR13 214 (15.5) 214 (100) 241 (25) 241 (100)
DR12 6 (0.4) 6 (100) 3 (0.3) 3 (100)
DR14 22 (1.6) 2 (9.1) 25 (2.6) 1 (4)
Totals 1378 621 (45.1) 403 (29.2) 964 248 (25.7) 427 (44.3)

BRASS, Brigham and Women's Rheumatoid Arthritis Sequential Study; HLA, human leucocyte antigen; RA, rheumatoid arthritis; SE, shared eipitope.